WIEBERS J L, GARNER H R
J Bacteriol. 1964 Dec;88(6):1798-804. doi: 10.1128/jb.88.6.1798-1804.1964.
Wiebers, Joyce L. (Purdue University, West Lafayette, Ind.), and Harold R. Garner. Use of S-methylcysteine and cystathionine by methionineless Neurospora mutants. J. Bacteriol. 88:1798-1804. 1964.-Radioactive methionine was found in hydrolysates of various strains of Neurospora crassa when either S-methylcysteine (SMC)-C(14)H(3) or SMC-S(35) is the sole addition to minimal medium. Isotope product-precursor specific activity ratios are very similar for the two sources of label. Wild-type and methionineless mutants use sulfur from SMC in the biosynthesis of methionine, but not of cysteine, when grown in regular medium. With a medium nearly free from sulfate, SMC served as a source of sulfur for both cysteine and methionine. Suppressed methionineless mutants incorporated sulfur from SMC into cellular cysteine even in the presence of normal amounts of sulfate. SMC as a possible metabolic precursor of methionine was compared to cystathionine in an experiment with wild-type Neurospora. The four sources of label used were: SMC-C(14)H(3), SMC-S(35), cystathionine-U-C(14), and cystathionine-S(35). In each flask, the organism was offered one of the labeled compounds plus an equivalent amount of the other compound without label. The amount of each compound was sufficient for either to supply its contribution to all of the cellular methionine, if it were successful in competing with endogenous sources. To avoid adaptive breakdown of substrates, the compounds were added continuously at a rate consistent with the amount of growth present. The ratio of specific activity of cellular methionine to precursor was determined for each labeled compound. The results show that SMC sulfur and methyl carbon are used equally well. Cystathionine carbon and sulfur appear to be equally utilized also. A preference for cystathionine is indicated.
维伯斯,乔伊斯·L.(普渡大学,印第安纳州西拉斐特),以及哈罗德·R.加纳。无蛋氨酸的粗糙脉孢菌突变体对S-甲基半胱氨酸和胱硫醚的利用。《细菌学杂志》88:1798 - 1804。1964年。——当向基本培养基中仅添加S-甲基半胱氨酸(SMC)-C(14)H(3)或SMC-S(35)时,在各种粗糙脉孢菌菌株的水解产物中发现了放射性蛋氨酸。两种标记来源的同位素产物 - 前体比活性非常相似。野生型和无蛋氨酸突变体在常规培养基中生长时,在蛋氨酸的生物合成中利用SMC中的硫,但不利用其合成半胱氨酸。在几乎不含硫酸盐的培养基中,SMC可作为半胱氨酸和蛋氨酸的硫源。即使在存在正常量硫酸盐的情况下,受抑制的无蛋氨酸突变体也能将SMC中的硫掺入细胞半胱氨酸中。在一项针对野生型粗糙脉孢菌的实验中,将SMC作为蛋氨酸可能的代谢前体与胱硫醚进行了比较。使用的四种标记来源是:SMC-C(14)H(3)、SMC-S(35)、胱硫醚 - U - C(14)和胱硫醚 - S(35)。在每个烧瓶中,向生物体提供一种标记化合物以及等量的另一种未标记化合物。如果每种化合物能够成功与内源性来源竞争,那么其数量足以提供其对所有细胞蛋氨酸的贡献。为避免底物的适应性分解,以与生长量一致的速率持续添加化合物。测定了每种标记化合物的细胞蛋氨酸比活性与前体的比值。结果表明,SMC的硫和甲基碳利用得同样好。胱硫醚的碳和硫似乎也被同等利用。表明对胱硫醚有偏好。